Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3282)
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.34
Total Value
$100.20K
Shares Held After
6,158,287
% of Holdings
0.5%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
179,058
Price
$1.80
Total Value
$321.57K
Shares Held After
5,436,447
% of Holdings
3.3%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$250.13
Total Value
$1.50M
Shares Held After
351,875
% of Holdings
1.7%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
19
Price
$2.02
Total Value
$38.38
Shares Held After
23,782
% of Holdings
0.1%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
525
Price
$12.62
Total Value
$6.63K
Shares Held After
525
% of Holdings
100.0%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
525
Price
$12.72
Total Value
$6.68K
Shares Held After
0
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.94
Total Value
$74.10K
Shares Held After
1,134,402
% of Holdings
1.3%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$46.99
Total Value
$422.87K
Shares Held After
65,389
% of Holdings
12.1%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
4,800
Price
$92.44
Total Value
$443.69K
Shares Held After
925,580
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
63,596
Price
$91.90
Total Value
$5.84M
Shares Held After
930,380
% of Holdings
6.4%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
6,604
Price
$90.79
Total Value
$599.56K
Shares Held After
993,976
% of Holdings
0.7%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
4,000
Price
$92.01
Total Value
$368.05K
Shares Held After
236,384
% of Holdings
1.7%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
1,000
Price
$91.05
Total Value
$91.05K
Shares Held After
240,384
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$8.49
Total Value
$127.31K
Shares Held After
1,639,208
% of Holdings
0.9%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.49
Total Value
$141.43K
Shares Held After
1,127,796
% of Holdings
1.5%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,356,053
% of Holdings
0.4%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,452
Price
$25.47
Total Value
$36.98K
Shares Held After
117,227
% of Holdings
1.2%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
15,000
Price
$5.86
Total Value
$87.97K
Shares Held After
62,065
% of Holdings
19.5%
CYTOKINETICS INC (CYTK)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$71.48
Total Value
$357.40K
Shares Held After
10,784
% of Holdings
31.7%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
10,000
Price
$12.11
Total Value
$121.10K
Shares Held After
124,411
% of Holdings
7.4%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
90,000
Price
$11.59
Total Value
$1.04M
Shares Held After
4,071,252
% of Holdings
2.2%
ALTERITY THERAPEUTICS LTD (ATHE)
Marks Peter Ashley — Director
Shares
47,620
Price
$0.50
Total Value
$23.81K
Shares Held After
191,340
% of Holdings
24.9%
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
10,000
Price
$3.96
Total Value
$39.60K
Shares Held After
10,000
% of Holdings
100.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
9,683
Price
$2.75
Total Value
$26.66K
Shares Held After
258,688
% of Holdings
3.6%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
34,463
Price
$2.67
Total Value
$91.90K
Shares Held After
1,226,427
% of Holdings
2.7%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
10,257
Price
$2.74
Total Value
$28.11K
Shares Held After
318,480
% of Holdings
3.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
403,571
Price
$1.79
Total Value
$722.59K
Shares Held After
5,257,389
% of Holdings
7.7%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
625
Price
$206.15
Total Value
$128.85K
Shares Held After
17,090
% of Holdings
3.5%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
2,128
Price
$205.19
Total Value
$436.64K
Shares Held After
17,715
% of Holdings
10.7%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
7,271
Price
$204.35
Total Value
$1.49M
Shares Held After
19,843
% of Holdings
26.8%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
26,160
Price
$203.55
Total Value
$5.32M
Shares Held After
27,114
% of Holdings
49.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
12,919
Price
$202.48
Total Value
$2.62M
Shares Held After
53,274
% of Holdings
19.5%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
6,597
Price
$201.47
Total Value
$1.33M
Shares Held After
66,193
% of Holdings
9.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
300
Price
$200.56
Total Value
$60.17K
Shares Held After
72,790
% of Holdings
0.4%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
1,099
Price
$10.24
Total Value
$11.25K
Shares Held After
366,529
% of Holdings
0.3%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
100,000
Price
$0.05
Total Value
$5.00K
Shares Held After
690,167
% of Holdings
14.5%
Quoin Pharmaceuticals, Ltd. (QNRX)
Carter Denise P. — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,709
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Myers Michael — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,713
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Lawlor Sally Bridget — Chief Financial Officer
Shares
10,244
Price
$4.88
Total Value
$49.99K
Shares Held After
10,684
% of Holdings
95.9%
Quoin Pharmaceuticals, Ltd. (QNRX)
Culverwell Anthony James — Director
Shares
6,146
Price
$4.88
Total Value
$29.99K
Shares Held After
40,364
% of Holdings
15.2%
NovaBridge Biosciences (NBP)
Xu Cong Claire — EVP, Clinical Development
Shares
3,282
Price
$0.79
Total Value
$2.59K
Shares Held After
304,201
% of Holdings
1.1%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,525
Price
$1.56
Total Value
$3.95K
Shares Held After
2,896
% of Holdings
46.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
28,188
Price
$106.20
Total Value
$2.99M
Shares Held After
114,024
% of Holdings
19.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
11,514
Price
$105.37
Total Value
$1.21M
Shares Held After
142,212
% of Holdings
7.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
23,072
Price
$104.59
Total Value
$2.41M
Shares Held After
153,726
% of Holdings
13.0%
FENNEC PHARMACEUTICALS INC. (FENC)
Sayad Pierre Sargis — Chief Medical Officer
Shares
12,000
Price
$12.18
Total Value
$146.16K
Shares Held After
9,519
% of Holdings
55.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
217
Price
$69.10
Total Value
$14.99K
Shares Held After
525,217
% of Holdings
0.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.23
Total Value
$341.18K
Shares Held After
525,000
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Showing 601–650 of 3282 transactions (page 13 of 66)